Robert Schlaberg
Impact in
- Microbiology top 0.2%
- Actinomycetales infections and treatment
- Small Animals top 2%
- Infectious Diseases and Mycology
Papers in ⓘ
-
- Bacterial Identification and Susceptibility Testing 6
- Co-authors
- Steve Miller (1 shared paper)Charles Y. Chiu (1 shared paper)George M. Weinstock (1 shared paper)Gary W. Procop (1 shared paper)Keith E. Simmon (6 shared papers)Mark Fisher (1 shared paper)Phyllis Della‐Latta (1 shared paper)Keith D. Tardif (9 shared papers)
- Journals
- Journal of Clinical Microbiology (7 papers)Open Forum Infectious Diseases (7 papers)Archives of Pathology & Laboratory Medicine (3 papers)Antimicrobial Agents and Chemotherapy (2 papers)Emerging infectious diseases (2 papers)
- Partner nations
- United StatesGermanyNorway
In The Last Decade
Robert Schlaberg
44 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Microbiology 219
- Small Animals 180
- Microbiology 146
- Clinical Biochemistry 156
- Epidemiology 661
Countries citing papers authored by Robert Schlaberg
This map shows the geographic impact of Robert Schlaberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Schlaberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Schlaberg more than expected).
Fields of papers citing papers by Robert Schlaberg
This network shows the impact of papers produced by Robert Schlaberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Schlaberg. The network helps show where Robert Schlaberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Schlaberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Validation of Metagenomic Next-Generation Sequencing Tests for Universal Pathogen Detection Hit paper breakdown → | 2017 | 371 |
| 2 | 2016 | 145 | |
| 3 | 2013 | 128 | |
| 4 | 2007 | 90 | |
| 5 | 2017 | 62 | |
| 6 | 2012 | 59 | |
| 7 | 2011 | 52 | |
| 8 | 2016 | 40 | |
| 9 | 2019 | 38 | |
| 10 | 2001 | 35 | |
| 11 | 2019 | 31 | |
| 12 | 2014 | 26 | |
| 13 | 2016 | 23 | |
| 14 | 2021 | 22 | |
| 15 | 2002 | 22 | |
| 16 | 2017 | 22 | |
| 17 | 2018 | 20 | |
| 18 | 2010 | 17 | |
| 19 | 2020 | 16 | |
| 20 | 2010 | 14 |
About Robert Schlaberg
Robert Schlaberg is a scholar working on Microbiology, Clinical Biochemistry, Infectious Diseases, Epidemiology and Microbiology, having authored 45 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (7 papers), Bacterial Identification and Susceptibility Testing (6 papers), Cervical Cancer and HPV Research (6 papers), Genomics and Phylogenetic Studies (5 papers), Molecular Biology Techniques and Applications (5 papers), Viral gastroenteritis research and epidemiology (5 papers), Respiratory viral infections research (4 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). The work is most often cited by research in Microbiology (219 citations), Small Animals (180 citations), Microbiology (146 citations), Clinical Biochemistry (156 citations) and Epidemiology (661 citations). Robert Schlaberg has collaborated with scholars based in United States, Germany and Norway. Frequent co-authors include Steve Miller, Charles Y. Chiu, George M. Weinstock, Gary W. Procop, Keith E. Simmon, Mark Fisher, Phyllis Della‐Latta, Keith D. Tardif, Richard C. Huard and Steven Flygare. Their work appears in journals such as Journal of Clinical Microbiology, Open Forum Infectious Diseases, Archives of Pathology & Laboratory Medicine, Antimicrobial Agents and Chemotherapy and Emerging infectious diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.